<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1.0"><!-- Inform modern browsers that this page supports both dark and light color schemes,
  and the page author prefers light. --><meta name="color-scheme" content="dark light"><script>
  // If `prefers-color-scheme` is not supported, fall back to light mode.
  // i.e. In this case, inject the `light` CSS before the others, with
  // no media filter so that it will be downloaded with highest priority.
  if (window.matchMedia("(prefers-color-scheme: dark)").media === "not all") {
    document.documentElement.style.display = "none";
    document.head.insertAdjacentHTML(
      "beforeend",
      "<link id=\"css\" rel=\"stylesheet\" href=\"https://bootswatch.com/3/flatly/bootstrap.css\" onload=\"document.documentElement.style.display = ''\">"
    );
  }
</script><title>Studies Investigating the Efficacy of P2Y12-Inhibitors in Atherosclerosis — dat.chiarito2020 • metadat</title><!-- jquery --><script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script><!-- Bootstrap --><script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script><!-- bootstrap-toc --><link rel="stylesheet" href="../bootstrap-toc.css"><script src="../bootstrap-toc.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet"><script src="../pkgdown.js"></script><!-- docsearch --><script src="../docsearch.js"></script><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/docsearch.js/2.6.3/docsearch.min.css" integrity="sha256-QOSRU/ra9ActyXkIBbiIB144aDBdtvXBcNc3OTNuX/Q=" crossorigin="anonymous"><link href="../docsearch.css" rel="stylesheet"><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/jquery.mark.min.js" integrity="sha256-4HLtjeVgH0eIB3aZ9mLYF6E8oU5chNdjU6p6rrXpl9U=" crossorigin="anonymous"></script><meta property="og:title" content="Studies Investigating the Efficacy of P2Y12-Inhibitors in Atherosclerosis — dat.chiarito2020"><meta property="og:description" content="Data on baseline parameters, efficacy endpoints and risk-of-bias from nine studies."><meta name="twitter:card" content="summary_large_image"><meta name="twitter:creator" content="@wviechtb"><meta name="twitter:site" content="@wviechtb"><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--><!-- Flatly Theme - Light  --><link id="css-light" rel="stylesheet" href="https://bootswatch.com/3/flatly/bootstrap.css" media="(prefers-color-scheme: light), (prefers-color-scheme: no-preference)"><!-- Darkly Theme - Dark --><link id="css-dark" rel="stylesheet" href="https://bootswatch.com/3/darkly/bootstrap.css" media="(prefers-color-scheme: dark)"><!-- preferably CSS --><link rel="stylesheet" href="../preferably.css"><link id="css-code-light" rel="stylesheet" href="../code-color-scheme-light.css" media="(prefers-color-scheme: light), (prefers-color-scheme: no-preference)"><link id="css-code-dark" rel="stylesheet" href="../code-color-scheme-dark.css" media="(prefers-color-scheme: dark)"><script src="../darkswitch.js"></script></head><body data-spy="scroll" data-target="#toc">


    <div class="container template-reference-topic">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">metadat</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="">1.5-5</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav"><li>
  <a href="../index.html">
    <span class="fa fa-home fa-lg"></span>

  </a>
</li>
<li>
  <a href="../reference/index.html">Datasets / Functions</a>
</li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul><ul class="nav navbar-nav navbar-right"><li>
          <a href="#" id="css-toggle-btn">
            <span class="fas fa-adjust fa-lg"></span>
          </a>
        </li>

        <li>
  <a href="https://scholar.social/@wviechtb" class="external-link">Mastodon</a>
</li>
<li>
  <a href="https://github.com/wviechtb/metadat" class="external-link">GitHub</a>
</li>




      </ul><form class="navbar-form navbar-right hidden-xs hidden-sm" role="search">
        <div class="form-group">
          <input type="search" class="form-control" name="search-input" id="search-input" placeholder="Search..." aria-label="Search for..." autocomplete="off"></div>
      </form>

    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->



      </header><div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>Studies Investigating the Efficacy of P2Y12-Inhibitors in Atherosclerosis</h1>

    <div class="hidden name"><code>dat.chiarito2020.Rd</code></div>
    </div>

    <div class="ref-description">
    <p>Data on baseline parameters, efficacy endpoints and risk-of-bias from nine studies.</p>
    </div>

    <div id="ref-usage">
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="va">dat.chiarito2020</span></span></code></pre></div>
    </div>

    <div id="format">
    <h2>Format</h2>
    <p>The data frame contains the following columns:</p><table class="table table"><tr><td><b>study</b></td><td><code>character</code></td><td>study identifier</td></tr><tr><td><b>year</b></td><td><code>numeric</code></td><td>publication year</td></tr><tr><td><b>p2y12</b></td><td><code>character</code></td><td>type of P2Y12 inhibitor</td></tr><tr><td><b>duration.months</b></td><td><code>numeric</code></td><td>study duration</td></tr><tr><td><b>p2y12.daily.dosage</b></td><td><code>character</code></td><td>daily dosage of P2Y12 inhibitor</td></tr><tr><td><b>aspirin.daily.dosage</b></td><td><code>character</code></td><td>daily dosage of aspirin</td></tr><tr><td><b>p2y12.daily.mg</b></td><td><code>numeric</code></td><td>daily dose of P2Y12 inhibitor (mg)</td></tr><tr><td><b>aspirin.daily.mg</b></td><td><code>numeric</code></td><td>daily dose of aspirin (mg)</td></tr><tr><td><b>baseline.age</b></td><td><code>numeric</code></td><td>mean age at baseline</td></tr><tr><td><b>baseline.males</b></td><td><code>numeric</code></td><td>proportion of males in study population</td></tr><tr><td><b>baseline.diabetes</b></td><td><code>numeric</code></td><td>proportion of diabetic patients in study population</td></tr><tr><td><b>baseline.hypertension</b></td><td><code>numeric</code></td><td>proportion of patients with hypertension in study population</td></tr><tr><td><b>baseline.dyslipidaemia</b></td><td><code>numeric</code></td><td>proportion of patients with dyslipidaemia in study population</td></tr><tr><td><b>p2y12.mi</b></td><td><code>numeric</code></td><td>number of patients with myocardial infarction in experimental group</td></tr><tr><td><b>p2y12.stroke</b></td><td><code>numeric</code></td><td>number of patients with stroke in experimental group</td></tr><tr><td><b>p2y12.death</b></td><td><code>numeric</code></td><td>number of deaths in experimental group</td></tr><tr><td><b>p2y12.vdeath</b></td><td><code>numeric</code></td><td>number of vascular deaths in experimental group</td></tr><tr><td><b>p2y12.total</b></td><td><code>numeric</code></td><td>total number of patients experimental group</td></tr><tr><td><b>aspirin.mi</b></td><td><code>numeric</code></td><td>number of patients with myocardial infarction in control group</td></tr><tr><td><b>aspirin.stroke</b></td><td><code>numeric</code></td><td>number of patients with stroke in control group</td></tr><tr><td><b>aspirin.death</b></td><td><code>numeric</code></td><td>number of deaths in control group</td></tr><tr><td><b>aspirin.vdeath</b></td><td><code>numeric</code></td><td>number of vascular deaths in control group</td></tr><tr><td><b>aspirin.total</b></td><td><code>numeric</code></td><td>total number of patients in control group</td></tr><tr><td><b>rob.R</b></td><td><code>factor</code></td><td>risk of bias arising from the randomization process (R)</td></tr><tr><td><b>rob.D</b></td><td><code>factor</code></td><td>risk of bias due to deviations from intended interventions (D)</td></tr><tr><td><b>rob.Mi</b></td><td><code>factor</code></td><td>risk of bias due to missing outcome data (Mi)</td></tr><tr><td><b>rob.Me</b></td><td><code>factor</code></td><td>risk of bias in measurement of the outcome (Me)</td></tr><tr><td><b>rob.S</b></td><td><code>factor</code></td><td>risk of bias in selection of the reported result (S)</td></tr><tr><td><b>rob.overall</b></td><td><code>factor</code></td><td>overall risk of bias</td></tr></table></div>
    <div id="details">
    <h2>Details</h2>
    <p>Chiarito et al. (2020) reviewed studies investigating the efficacy of P2Y12-inhibitors (compared to aspirin) for the secondary prevention of myocardial infarction in patients with established atherosclerosis.</p>
<p>A diagnosis of atherosclerosis, the development of lesions in arteries, is a risk factor for myocardial infarction or stroke, and a range of therapies (including aspirin, other drugs, or surgery) are available. P2Y12-inhibitors are antiplatelet drugs and as such might serve as an alternative to the commonly used aspirin; it was of interest to review and summarize the current scientific evidence on the efficacy of this type of drug in comparison to aspirin. To this end, Chiarito et al. (2020) performed a systematic review and meta-analysis; the systematic review had been pre-registered (PROSPERO CRD42018115037), and the investigation included a risk-of-bias assessment of the nine studies included. Co-primary endpoints were myocardial infarction and stroke, secondary endpoints were death and vascular death.</p>
    </div>
    <div id="source">
    <h2>Source</h2>
    <p>Chiarito, M., Sanz-Sánchez, J., Cannata, F., Cao, D., Sturla, M., Panico, C., Godino, C., Regazzoli, D., Reimers, B., De Caterina, R., Condorelli, G., Ferrante, G., &amp; Stefanini, G. G. (2020). Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: A systematic review and meta-analysis. <em>The Lancet</em>, <b>395</b>(10235), 1487–1495. <a href="https://doi.org/10.1016/s0140-6736(20)30315-9" class="external-link">https://doi.org/10.1016/s0140-6736(20)30315-9</a></p>
    </div>
    <div id="author">
    <h2>Author</h2>
    <p>Christian Röver, <a href="mailto:christian.roever@med.uni-goettingen.de">christian.roever@med.uni-goettingen.de</a></p>
    </div>
    <div id="references">
    <h2>References</h2>
    <p>Zapf, A., Röver, C. (2023). Metaanalyse. In J. Gertheiss, M. Schmid, &amp; M. Spindler (Eds.), <em>Moderne Verfahren der Angewandten Statistik</em>. Berlin, Germany: Springer Spektrum. <a href="https://doi.org/10.1007/978-3-662-63496-7_19-1" class="external-link">https://doi.org/10.1007/978-3-662-63496-7_19-1</a></p>
    </div>
    <div id="concepts">
    <h2>Concepts</h2>
    <p>medicine, cardiology, odds ratios, risk-of-bias</p>
    </div>

    <div id="ref-examples">
    <h2>Examples</h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="va">dat.chiarito2020</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span>      study year       p2y12 duration.months p2y12.daily.dosage aspirin.daily.dosage p2y12.daily.mg</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1     TASS 1989 ticlopidine              36        250mg twice          650mg twice            500</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2   CAPRIE 1996 clopidogrel              36          75mg once           325mg once             75</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3    STAMI 2001 ticlopidine               6        250mg twice           80mg twice            500</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4   AAASPS 2003 ticlopidine              24        250mg twice          325mg twice            500</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 5    CADET 2004 clopidogrel               6          75mg once            75mg once             75</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6    ASCET 2012 clopidogrel              24          75mg once            75mg once             75</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7 SOCRATES 2016  ticagrelor               3         90mg twice           100mg once            180</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8    DACAB 2018  ticagrelor              12         90mg twice           100mg once            180</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9    TiCAB 2019  ticagrelor              12         90mg twice           100mg once            180</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   aspirin.daily.mg baseline.age baseline.males baseline.diabetes baseline.hypertension</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1             1300         62.9          0.647             0.194                 0.392</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2              325         62.5          0.719             0.200                 0.515</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3              160         59.2          0.838             0.149                 0.336</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4              650         61.3          0.465             0.407                 0.850</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 5               75         62.6          0.809                NA                    NA</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6               75         62.4          0.782             0.199                 0.554</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7              100         65.8          0.584             0.243                 0.737</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8              100         63.6          0.828             0.427                 0.728</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9              100         66.7          0.849             0.359                 0.899</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   baseline.dyslipidaemia p2y12.mi p2y12.stroke p2y12.death p2y12.vdeath p2y12.total aspirin.mi</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1                  0.365       NA          162         175          120        1529         NA</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2                  0.410      275          438         560          373        9599        333</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3                  0.360        8            4           7            6         734         18</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4                  0.385        9          106          45           23         902          8</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 5                     NA        1           NA           5           NA          94          6</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6                     NA       18           11           5           NA         499         18</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7                  0.380       25          385          68           41        6589         21</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8                  0.731        2            2           0            0         166          3</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9                  0.817       19           29          22           11         931         30</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   aspirin.stroke aspirin.death aspirin.vdeath aspirin.total         rob.R         rob.D   rob.Mi</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1            201           196            116          1540 some concerns      low risk low risk</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2            462           571            405          9586      low risk      low risk low risk</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3              3             5              5           736 some concerns      low risk low risk</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4             86            40             19           907      low risk some concerns low risk</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 5             NA             3             NA            90      low risk      low risk low risk</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6             17             4             NA           502      low risk some concerns low risk</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7            441            58             35          6610      low risk      low risk low risk</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8              4             3              2           166      low risk some concerns low risk</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9             21            23             13           928      low risk      low risk low risk</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>          rob.Me         rob.S   rob.overall</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1      low risk      low risk some concerns</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2      low risk      low risk      low risk</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3      low risk      low risk some concerns</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4      low risk      low risk some concerns</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 5      low risk      low risk      low risk</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6      low risk      low risk some concerns</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7      low risk      low risk      low risk</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8      low risk      low risk some concerns</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9 some concerns some concerns some concerns</span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="kw"><a href="https://rdrr.io/r/base/library.html" class="external-link">library</a></span><span class="op">(</span><span class="va"><a href="https://www.metafor-project.org" class="external-link">metafor</a></span><span class="op">)</span></span></span>
<span class="r-in"><span><span class="kw"><a href="https://rdrr.io/r/base/library.html" class="external-link">library</a></span><span class="op">(</span><span class="va"><a href="https://github.com/guido-s/meta/" class="external-link">meta</a></span><span class="op">)</span></span></span>
<span class="r-in"><span><span class="kw"><a href="https://rdrr.io/r/base/library.html" class="external-link">library</a></span><span class="op">(</span><span class="va"><a href="https://gitlab.gwdg.de/croever/bayesmeta" class="external-link">bayesmeta</a></span><span class="op">)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># show plain data on stroke</span></span></span>
<span class="r-in"><span><span class="va">dat.chiarito2020</span><span class="op">[</span><span class="op">-</span><span class="fl">5</span>, <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"study"</span>,<span class="st">"p2y12.stroke"</span>,<span class="st">"p2y12.total"</span>,<span class="st">"aspirin.stroke"</span>,<span class="st">"aspirin.total"</span><span class="op">)</span><span class="op">]</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span>      study p2y12.stroke p2y12.total aspirin.stroke aspirin.total</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1     TASS          162        1529            201          1540</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2   CAPRIE          438        9599            462          9586</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3    STAMI            4         734              3           736</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4   AAASPS          106         902             86           907</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6    ASCET           11         499             17           502</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7 SOCRATES          385        6589            441          6610</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8    DACAB            2         166              4           166</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9    TiCAB           29         931             21           928</span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># show event rates in both treatment groups</span></span></span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/base/cbind.html" class="external-link">cbind.data.frame</a></span><span class="op">(</span><span class="st">"study"</span>   <span class="op">=</span> <span class="va">dat.chiarito2020</span><span class="op">$</span><span class="va">study</span>,</span></span>
<span class="r-in"><span>                 <span class="st">"p2y12"</span>   <span class="op">=</span> <span class="va">dat.chiarito2020</span><span class="op">$</span><span class="va">p2y12.stroke</span> <span class="op">/</span> <span class="va">dat.chiarito2020</span><span class="op">$</span><span class="va">p2y12.total</span>,</span></span>
<span class="r-in"><span>                 <span class="st">"aspirin"</span> <span class="op">=</span> <span class="va">dat.chiarito2020</span><span class="op">$</span><span class="va">aspirin.stroke</span> <span class="op">/</span> <span class="va">dat.chiarito2020</span><span class="op">$</span><span class="va">aspirin.total</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span>      study       p2y12     aspirin</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1     TASS 0.105951602 0.130519481</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2   CAPRIE 0.045629753 0.048195285</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3    STAMI 0.005449591 0.004076087</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4   AAASPS 0.117516630 0.094818082</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 5    CADET          NA          NA</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6    ASCET 0.022044088 0.033864542</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7 SOCRATES 0.058430718 0.066717095</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8    DACAB 0.012048193 0.024096386</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9    TiCAB 0.031149302 0.022629310</span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># compute effect measures (log-ORs)</span></span></span>
<span class="r-in"><span><span class="co"># (using the "escalc()" function from the "metafor" package)</span></span></span>
<span class="r-in"><span><span class="va">es.stroke</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://wviechtb.github.io/metafor/reference/escalc.html" class="external-link">escalc</a></span><span class="op">(</span>measure<span class="op">=</span><span class="st">"OR"</span>,</span></span>
<span class="r-in"><span>                    ai<span class="op">=</span><span class="va">p2y12.stroke</span>,   n1i<span class="op">=</span><span class="va">p2y12.total</span>,</span></span>
<span class="r-in"><span>                    ci<span class="op">=</span><span class="va">aspirin.stroke</span>, n2i<span class="op">=</span><span class="va">aspirin.total</span>,</span></span>
<span class="r-in"><span>                    slab<span class="op">=</span><span class="va">study</span>, subset<span class="op">=</span><span class="fu"><a href="https://rdrr.io/r/base/is.finite.html" class="external-link">is.finite</a></span><span class="op">(</span><span class="va">p2y12.stroke</span><span class="op">)</span>,</span></span>
<span class="r-in"><span>                    data<span class="op">=</span><span class="va">dat.chiarito2020</span><span class="op">)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># show effect measures (log-ORs)</span></span></span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary</a></span><span class="op">(</span><span class="va">es.stroke</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>      study year       p2y12 duration.months p2y12.daily.dosage aspirin.daily.dosage p2y12.daily.mg </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1     TASS 1989 ticlopidine              36        250mg twice          650mg twice            500 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2   CAPRIE 1996 clopidogrel              36          75mg once           325mg once             75 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3    STAMI 2001 ticlopidine               6        250mg twice           80mg twice            500 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4   AAASPS 2003 ticlopidine              24        250mg twice          325mg twice            500 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6    ASCET 2012 clopidogrel              24          75mg once            75mg once             75 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7 SOCRATES 2016  ticagrelor               3         90mg twice           100mg once            180 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8    DACAB 2018  ticagrelor              12         90mg twice           100mg once            180 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9    TiCAB 2019  ticagrelor              12         90mg twice           100mg once            180 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   aspirin.daily.mg baseline.age baseline.males baseline.diabetes baseline.hypertension </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1             1300         62.9          0.647             0.194                 0.392 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2              325         62.5          0.719             0.200                 0.515 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3              160         59.2          0.838             0.149                 0.336 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4              650         61.3          0.465             0.407                 0.850 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6               75         62.4          0.782             0.199                 0.554 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7              100         65.8          0.584             0.243                 0.737 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8              100         63.6          0.828             0.427                 0.728 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9              100         66.7          0.849             0.359                 0.899 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   baseline.dyslipidaemia p2y12.mi p2y12.stroke p2y12.death p2y12.vdeath p2y12.total aspirin.mi </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1                  0.365       NA          162         175          120        1529         NA </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2                  0.410      275          438         560          373        9599        333 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3                  0.360        8            4           7            6         734         18 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4                  0.385        9          106          45           23         902          8 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6                     NA       18           11           5           NA         499         18 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7                  0.380       25          385          68           41        6589         21 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8                  0.731        2            2           0            0         166          3 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9                  0.817       19           29          22           11         931         30 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   aspirin.stroke aspirin.death aspirin.vdeath aspirin.total         rob.R         rob.D   rob.Mi </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1            201           196            116          1540 some concerns      low risk low risk </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2            462           571            405          9586      low risk      low risk low risk </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3              3             5              5           736 some concerns      low risk low risk </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4             86            40             19           907      low risk some concerns low risk </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6             17             4             NA           502      low risk some concerns low risk </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7            441            58             35          6610      low risk      low risk low risk </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8              4             3              2           166      low risk some concerns low risk </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9             21            23             13           928      low risk      low risk low risk </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>          rob.Me         rob.S   rob.overall      yi     vi    sei      zi   pval   ci.lb   ci.ub </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1      low risk      low risk some concerns -0.2364 0.0126 0.1124 -2.1039 0.0354 -0.4566 -0.0162 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2      low risk      low risk      low risk -0.0574 0.0047 0.0683 -0.8402 0.4008 -0.1913  0.0765 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3      low risk      low risk some concerns  0.2918 0.5861 0.7656  0.3811 0.7031 -1.2087  1.7922 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4      low risk      low risk some concerns  0.2400 0.0235 0.1534  1.5645 0.1177 -0.0607  0.5407 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6      low risk      low risk some concerns -0.4415 0.1538 0.3922 -1.1256 0.2603 -1.2102  0.3273 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7      low risk      low risk      low risk -0.1415 0.0052 0.0720 -1.9639 0.0495 -0.2826 -0.0003 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8      low risk      low risk some concerns -0.7054 0.7623 0.8731 -0.8080 0.4191 -2.4166  1.0058 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9 some concerns some concerns some concerns  0.3283 0.0843 0.2904  1.1306 0.2582 -0.2408  0.8974 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># show effect measures (ORs und 95 percent CI)</span></span></span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/base/cbind.html" class="external-link">cbind</a></span><span class="op">(</span><span class="st">"study"</span> <span class="op">=</span> <span class="va">es.stroke</span><span class="op">$</span><span class="va">study</span>,</span></span>
<span class="r-in"><span>      <span class="fu"><a href="https://rdrr.io/r/base/Log.html" class="external-link">exp</a></span><span class="op">(</span><span class="fu"><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary</a></span><span class="op">(</span><span class="va">es.stroke</span><span class="op">)</span><span class="op">[</span>,<span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"yi"</span>,<span class="st">"ci.lb"</span>,<span class="st">"ci.ub"</span><span class="op">)</span><span class="op">]</span><span class="op">)</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>      study     yi  ci.lb  ci.ub </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1     TASS 0.7895 0.6334 0.9840 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2   CAPRIE 0.9442 0.8259 1.0795 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3    STAMI 1.3388 0.2986 6.0029 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4   AAASPS 1.2713 0.9411 1.7172 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 6    ASCET 0.6431 0.2981 1.3872 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 7 SOCRATES 0.8681 0.7538 0.9997 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8    DACAB 0.4939 0.0892 2.7341 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 9    TiCAB 1.3886 0.7860 2.4532 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># show data in a forest plot</span></span></span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/pkg/forestplot/man/forestplot.html" class="external-link">forestplot</a></span><span class="op">(</span><span class="va">es.stroke</span>, xlab<span class="op">=</span><span class="st">"log-OR"</span><span class="op">)</span></span></span>
<span class="r-plt img"><img src="dat.chiarito2020-1.png" alt="" width="1728" height="1536"></span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/pkg/forestplot/man/forestplot.html" class="external-link">forestplot</a></span><span class="op">(</span><span class="va">es.stroke</span>, expo<span class="op">=</span><span class="cn">TRUE</span>, xlog<span class="op">=</span><span class="cn">TRUE</span>, xlab<span class="op">=</span><span class="st">"odds ratio (OR)"</span><span class="op">)</span></span></span>
<span class="r-plt img"><img src="dat.chiarito2020-2.png" alt="" width="1728" height="1536"></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co">############################################################</span></span></span>
<span class="r-in"><span><span class="co">#  meta-analysis (frequentist, "metafor" package)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># using default settings (random-effects model, REML-estimator)</span></span></span>
<span class="r-in"><span><span class="fu"><a href="https://wviechtb.github.io/metafor/reference/rma.uni.html" class="external-link">rma.uni</a></span><span class="op">(</span><span class="va">es.stroke</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Random-Effects Model (k = 8; tau^2 estimator: REML)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> tau^2 (estimated amount of total heterogeneity): 0.0131 (SE = 0.0180)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> tau (square root of estimated tau^2 value):      0.1144</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> I^2 (total heterogeneity / total variability):   41.78%</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> H^2 (total variability / sampling variability):  1.72</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Test for Heterogeneity:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Q(df = 7) = 10.6797, p-val = 0.1532</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Model Results:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> estimate      se     zval    pval    ci.lb   ci.ub    </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  -0.0678  0.0713  -0.9499  0.3422  -0.2076  0.0720    </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> ---</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># analysis using Paule-Mandel estimator and HKSJ intervals</span></span></span>
<span class="r-in"><span><span class="va">rma01</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://wviechtb.github.io/metafor/reference/rma.uni.html" class="external-link">rma.uni</a></span><span class="op">(</span><span class="va">es.stroke</span>, method<span class="op">=</span><span class="st">"PM"</span>, test<span class="op">=</span><span class="st">"knha"</span><span class="op">)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># show results</span></span></span>
<span class="r-in"><span><span class="va">rma01</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Random-Effects Model (k = 8; tau^2 estimator: PM)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> tau^2 (estimated amount of total heterogeneity): 0.0144 (SE = 0.0230)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> tau (square root of estimated tau^2 value):      0.1198</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> I^2 (total heterogeneity / total variability):   44.07%</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> H^2 (total variability / sampling variability):  1.79</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Test for Heterogeneity:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Q(df = 7) = 10.6797, p-val = 0.1532</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Model Results:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> estimate      se     tval  df    pval    ci.lb   ci.ub    </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  -0.0666  0.0733  -0.9090   7  0.3936  -0.2398  0.1066    </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> ---</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># illustrate in a forest plot</span></span></span>
<span class="r-in"><span><span class="fu"><a href="https://wviechtb.github.io/metafor/reference/forest.html" class="external-link">forest</a></span><span class="op">(</span><span class="va">rma01</span><span class="op">)</span></span></span>
<span class="r-plt img"><img src="dat.chiarito2020-3.png" alt="" width="1728" height="1536"></span>
<span class="r-in"><span><span class="fu"><a href="https://wviechtb.github.io/metafor/reference/forest.html" class="external-link">forest</a></span><span class="op">(</span><span class="va">rma01</span>, atransf<span class="op">=</span><span class="va">exp</span><span class="op">)</span></span></span>
<span class="r-plt img"><img src="dat.chiarito2020-4.png" alt="" width="1728" height="1536"></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co">############################################################</span></span></span>
<span class="r-in"><span><span class="co">#  meta-analysis (frequentist, "meta" package)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># analogous analysis to above, using the "meta" package</span></span></span>
<span class="r-in"><span><span class="va">meta01</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/meta/man/metabin.html" class="external-link">metabin</a></span><span class="op">(</span>event.e<span class="op">=</span><span class="va">p2y12.stroke</span>,   n.e<span class="op">=</span><span class="va">p2y12.total</span>,</span></span>
<span class="r-in"><span>                  event.c<span class="op">=</span><span class="va">aspirin.stroke</span>, n.c<span class="op">=</span><span class="va">aspirin.total</span>,</span></span>
<span class="r-in"><span>                  studlab<span class="op">=</span><span class="va">study</span>, data<span class="op">=</span><span class="va">dat.chiarito2020</span>,</span></span>
<span class="r-in"><span>                  subset<span class="op">=</span><span class="fu"><a href="https://rdrr.io/r/base/is.finite.html" class="external-link">is.finite</a></span><span class="op">(</span><span class="va">p2y12.stroke</span><span class="op">)</span>,</span></span>
<span class="r-in"><span>                  sm<span class="op">=</span><span class="st">"OR"</span>,</span></span>
<span class="r-in"><span>                  method.tau<span class="op">=</span><span class="st">"PM"</span>,</span></span>
<span class="r-in"><span>                  method.random.ci<span class="op">=</span><span class="st">"HK"</span>, method<span class="op">=</span><span class="st">"Inverse"</span><span class="op">)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="va">meta01</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Number of studies: k = 8</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Number of observations: o = 41924 (o.e = 20949, o.c = 20975)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Number of events: e = 2372</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          OR           95%-CI   z|t p-value</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Common effect model  0.9173 [0.8437; 0.9972] -2.02  0.0429</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Random effects model 0.9356 [0.7868; 1.1125] -0.91  0.3936</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Quantifying heterogeneity (with 95%-CIs):</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  tau^2 = 0.0144 [0.0000; 0.2873]; tau = 0.1198 [0.0000; 0.5360]</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  I^2 = 34.5% [0.0%; 71.0%]; H = 1.24 [1.00; 1.86]</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Test of heterogeneity:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>      Q d.f. p-value</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  10.68    7  0.1532</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Details of meta-analysis methods:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> - Inverse variance method</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> - Paule-Mandel estimator for tau^2</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> - Q-Profile method for confidence interval of tau^2 and tau</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> - Calculation of I^2 based on Q</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> - Hartung-Knapp adjustment for random effects model (df = 7)</span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary</a></span><span class="op">(</span><span class="va">meta01</span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span>              OR           95%-CI %W(common) %W(random)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> TASS     0.7895 [0.6334; 0.9840]       14.4       19.9</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> CAPRIE   0.9442 [0.8259; 1.0795]       39.0       28.2</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> STAMI    1.3388 [0.2986; 6.0029]        0.3        0.9</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> AAASPS   1.2713 [0.9411; 1.7172]        7.7       14.2</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> ASCET    0.6431 [0.2981; 1.3872]        1.2        3.2</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> SOCRATES 0.8681 [0.7538; 0.9997]       35.0       27.5</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> DACAB    0.4939 [0.0892; 2.7341]        0.2        0.7</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> TiCAB    1.3886 [0.7860; 2.4532]        2.2        5.4</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Number of studies: k = 8</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Number of observations: o = 41924 (o.e = 20949, o.c = 20975)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Number of events: e = 2372</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          OR           95%-CI   z|t p-value</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Common effect model  0.9173 [0.8437; 0.9972] -2.02  0.0429</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Random effects model 0.9356 [0.7868; 1.1125] -0.91  0.3936</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Quantifying heterogeneity (with 95%-CIs):</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  tau^2 = 0.0144 [0.0000; 0.2873]; tau = 0.1198 [0.0000; 0.5360]</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  I^2 = 34.5% [0.0%; 71.0%]; H = 1.24 [1.00; 1.86]</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Test of heterogeneity:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>      Q d.f. p-value</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  10.68    7  0.1532</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Details of meta-analysis methods:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> - Inverse variance method</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> - Paule-Mandel estimator for tau^2</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> - Q-Profile method for confidence interval of tau^2 and tau</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> - Calculation of I^2 based on Q</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> - Hartung-Knapp adjustment for random effects model (df = 7)</span>
<span class="r-in"><span><span class="fu"><a href="https://wviechtb.github.io/metafor/reference/forest.html" class="external-link">forest</a></span><span class="op">(</span><span class="va">meta01</span><span class="op">)</span></span></span>
<span class="r-plt img"><img src="dat.chiarito2020-5.png" alt="" width="1728" height="1536"></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co">############################################################</span></span></span>
<span class="r-in"><span><span class="co">#  meta-analysis (Bayesian, "bayesmeta" package)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># analysis using default settings (uniform prior for mu und tau)</span></span></span>
<span class="r-in"><span><span class="va">bma01</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/bayesmeta/man/bayesmeta.html" class="external-link">bayesmeta</a></span><span class="op">(</span><span class="va">es.stroke</span><span class="op">)</span></span></span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># show results</span></span></span>
<span class="r-in"><span><span class="va">bma01</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  'bayesmeta' object.</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 8 estimates:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> TASS, CAPRIE, STAMI, AAASPS, ASCET, SOCRATES, DACAB, TiCAB</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> tau prior (improper):</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> uniform(min=0, max=Inf) </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> mu prior (improper):</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> uniform(min=-Inf, max=Inf)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> ML and MAP estimates:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                       tau          mu</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> ML joint     0.000000e+00 -0.08633440</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> ML marginal  1.143849e-01 -0.07697409</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> MAP joint    3.852512e-06 -0.08633224</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> MAP marginal 1.143878e-01 -0.07699909</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> marginal posterior summary:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                 tau          mu</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> mode      0.1143878 -0.07699909</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> median    0.1604488 -0.06874389</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> mean      0.1934478 -0.06373887</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> sd        0.1553690  0.11481488</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 95% lower 0.0000000 -0.28867455</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 95% upper 0.4798347  0.18065023</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> (quoted intervals are shortest credible intervals.)</span>
<span class="r-in"><span></span></span>
<span class="r-in"><span><span class="co"># show forest plots (for log-OR and OR)</span></span></span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/pkg/forestplot/man/forestplot.html" class="external-link">forestplot</a></span><span class="op">(</span><span class="va">bma01</span>, xlab<span class="op">=</span><span class="st">"log-OR"</span><span class="op">)</span></span></span>
<span class="r-plt img"><img src="dat.chiarito2020-6.png" alt="" width="1728" height="1536"></span>
<span class="r-in"><span><span class="fu"><a href="https://rdrr.io/pkg/forestplot/man/forestplot.html" class="external-link">forestplot</a></span><span class="op">(</span><span class="va">bma01</span>, exponentiate<span class="op">=</span><span class="cn">TRUE</span>, xlog<span class="op">=</span><span class="cn">TRUE</span>, xlab<span class="op">=</span><span class="st">"OR"</span><span class="op">)</span></span></span>
<span class="r-plt img"><img src="dat.chiarito2020-7.png" alt="" width="1728" height="1536"></span>
</code></pre></div>
    </div>
  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">
    <nav id="toc" data-toggle="toc" class="sticky-top"><h2 data-toc-skip>Contents</h2>
    </nav></div>
</div>


      <footer><div class="copyright">
  <p></p><p>Developed by Wolfgang Viechtbauer, Thomas White, Daniel Noble, Alistair Senior, W. Kyle Hamilton.</p>
</div>

<div class="pkgdown">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.2.0.</p>
  <p class="preferably">Using <a href="https://preferably.amirmasoudabdol.name/?source=footer" class="external-link">preferably</a> template.</p>
</div>

      </footer></div>


<script src="https://cdnjs.cloudflare.com/ajax/libs/docsearch.js/2.6.1/docsearch.min.js" integrity="sha256-GKvGqXDznoRYHCwKXGnuchvKSwmx9SRMrZOTh2g4Sb0=" crossorigin="anonymous"></script><script>
  docsearch({
    appId: 'B3DHC2OOU8',

    apiKey: '8c74dd1e0cd05800bf9f222777e07625',
    indexName: 'wviechtb-metadat',
    inputSelector: 'input#search-input.form-control',
    transformData: function(hits) {
      return hits.map(function (hit) {
        hit.url = updateHitURL(hit);
        return hit;
      });
    }
  });
</script></body></html>

